-
Loading metrics
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
- Yu Kato,
- Kimiyo Tabata,
- Takayuki Kimura,
- Ayako Yachie-Kinoshita,
- Yoichi Ozawa,
- Kazuhiko Yamada,
- Junichi Ito,
- Sho Tachino,
- Yusaku Hori,
- Masahiro Matsuki
x
- Published: February 27, 2019
- https://doi.org/10.1371/journal.pone.0212513